Oslo University Hospital
Oslo, 0424, Norway
NCT Number: NCT01342809
The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Oslo, 0424, Norway
Patients hospitalized after an episode of self poisoning will be randomly assigned into intervention an control groups. The intervention is close follow up by general practitioner six months. Both groups will receive treatment as usual.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Follow up, consultations with general practitioner, written guidelines, supervision.
Other names: General Practitioner
Time frame: 3 and 6 months
Beck Cepression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale
Time frame: 3 and 6 months
Beck Depression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale
Time frame: 3 and 6 months
Contacts with GP, and health care services, satisfaction with treatment GP (EUROPEP)
Oslo University Hospital
Other
Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01826240
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT07012824
Behavior, Behavioral Symptoms
Athens, Georgia, United States
View Trial DetailsNCT01502319
Behavior, Behavioral Symptoms
Denver, Colorado, United States
View Trial DetailsNCT01528020
Behavior, Behavioral Symptoms
Seattle, Washington, United States
View Trial Details